Articles From: Apple shields information in GT Advanced creditor probe to Philadelphia Agency Sues Gilead Over Price Of Hepatitis Drug--Update


By Peg Brickley Creditors of failed smartphone screen material supplier GT Advanced Technologies will get a peek at Apple Inc.'s secrets under a protective court order signed Tuesday.
Sign-up for Apple shields information in GT Advanced creditor probe investment picks
By Peg Brickley GT Advanced Technologies has signed a pact with Apple Inc. for an "amicable parting of the ways," Luc Despins, attorney for the bankrupt supplier to the technology giant, said Tuesday in the U.S. Bankruptcy Court in New Hampshire.
Sign-up for GT Advanced, Apple in deal for 'amicable' split-up investment picks
2014/11/20
By Pervaiz Shallwani and Christina RexrodeCiti officials confirmed Wednesday that Shawn Miller was found dead A Citigroup Inc. executive was found dead in the bathtub of his home in Manhattan on Tuesday from an apparent slash wound to the neck, New York City authorities said.
Sign-up for UPDATE: Citi exec found dead in Manhattan apartment investment picks
2014/11/27
By Peter Evans And Mike Esterl Coca-Cola Co.
Sign-up for Coca-Cola, SABMiller Strike New Africa Deal -- 3rd Update investment picks
By Peter Evans LONDON --
Sign-up for Tesco chairman to step down after history of accounting errors investment picks
2014/11/27
By Peter Evans LONDON-- SABMiller PLC and Coca-Cola Co.
Sign-up for Coca-Cola, SABMiller Strike New Africa Deal -- 2nd Update investment picks
2014/11/27
By Peter Evans LONDON-- SABMiller PLC and Coca-Cola Co.
Sign-up for Coca-Cola, SABMiller Strike New Africa Deal -- Update investment picks
2014/12/9
By Peter Evans LONDON--
Sign-up for Tesco Issues Profit Warning -- 4th Update investment picks
2014/12/9
By Peter Evans LONDON-- Tesco PLC on Tuesday slashed its full-year profit forecast as the British retailer continued to pay the price for a recent accounting scandal and years of underinvestment in its home market.
Sign-up for Tesco Issues Profit Warning -- 3rd Update investment picks
2014/12/4
By Peter Evans LONDON--
Sign-up for Unilever to Separate Spreads Division -- 2nd Update investment picks
2014/11/25
By Peter Evans LONDON--Black Friday used to be just another rainy day in November for retailers in the U.K., where Thanksgiving isn't a holiday.
Sign-up for U.K. Retailers Embrace Black Friday investment picks
2014/11/19
By Peter Evans LONDON--Every drop of palm oil used by Unilever PLC's European food business, in products from Magnum ice cream to I Can't Believe It's Not Butter spreads, will come from sustainable sources by the end of 2014, the company said Wednesday.
Sign-up for Unilever to use only sustainable palm oil in European foods by year-end investment picks
2014/12/12
By Peter Evans LONDON--The dramatic fall in the ruble is starting to hurt Western multinationals, adding to their list of problems in Russia after a year of turmoil.
Sign-up for Decline in Ruble Starting to Hurt Western Multinationals investment picks
2014/12/4
By Peter EvansAdmits unit was a drag on business LONDON -- Unilever PLC will separate its struggling spreads division into a stand-alone company after the consumer-products giant admitted it was a drag on the rest of its business.
Sign-up for Unilever to split off spreads division investment picks
2014/12/4
By Peter EvansAdmits unit was a drag on business LONDON -- Unilever PLC will separate its struggling spreads division into a stand-alone company after the consumer-products giant admitted it was a drag on the rest of its business.
Sign-up for UPDATE: Unilever to separate spreads division investment picks
2014/11/27
By Peter EvansAfrican bottler will have annual revenue of $2.9 billion LONDON -- SABMiller PLC and Coca-Cola Co.
Sign-up for Coca-Cola, SABMiller strike deal to create African bottling company investment picks
2014/11/28
By Peter Finch One frequent knock on individual investors: They're prone to tampering with their assets.
Sign-up for How to X-Ray Your Portfolio investment picks
By Peter Grant Blackstone Group LP (BX) has reached a binding deal to sell its portfolio of U.S. industrial property to a venture including GIC Pte Ltd and Global Logistic Properties Ltd.
Sign-up for Blackstone gets deal to sell IndCor for $8.1 billion investment picks
2014/12/2
By Peter Grant GIC Pte.
Sign-up for Blackstone to Sell IndCor to GIC Venture for $8.1 Billion -- Update investment picks
2014/12/2
By Peter Grant Singapore's sovereign-wealth fund is making a big bet on U.S. industrial property, as a strengthening American economy and the growth of online shopping fuel demand for warehouses and distribution centers.
Sign-up for Singapore's GIC Fund Wagers on U.S. Property investment picks
2014/12/10
By Peter Loftus A Merck & Co.
Sign-up for UPDATE: Merck drug shrank tumors in some breast cancer patients in trial investment picks
2014/12/8
By Peter Loftus and Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update investment picks
2014/12/8
By Peter Loftus And Dana Cimilluca Merck & Co.
Sign-up for Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 3rd Update investment picks
2014/12/8
By Peter Loftus and Dana CimillucaThe per-share bid of $102 is 37% above Friday's closing price of Cubist's stock Drug giant Merck & Co.
Sign-up for Merck to buy Cubist Pharmaceuticals for $8.4 billion investment picks
By Peter Loftus Chimerix Inc. said Thursday it plans to conduct a clinical trial of its experimental antiviral drug in patients with the Ebola virus.
Sign-up for Chimerix to conduct Ebola drug trial investment picks
2014/11/24
By Peter Loftus Merck & Co.
Sign-up for Merck obtains right to experimental Ebola vaccine investment picks
2014/12/10
By Peter Loftus Philadelphia's transit agency filed a lawsuit against Gilead Sciences Inc., accusing the company of price-gouging on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the latest salvo in a battle between some health-care payers and the pharmaceutical industry over prices.
Sign-up for Philadelphia Transit Agency Sues Gilead, Claiming Sovaldi Price-Gouging investment picks
2014/12/10
By Peter Loftus Philadelphia's transit agency has sued Gilead Sciences Inc., accusing the company of "price-gouging" on the sale of its $1,000-per-pill hepatitis C drug Sovaldi, the latest salvo in a battle between health-care payers and the pharmaceutical industry over prices.
Sign-up for Philadelphia Agency Sues Gilead Over Price Of Hepatitis Drug--Update investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Apple shields information in GT Advanced creditor probe to Philadelphia Agency Sues Gilead Over Price Of Hepatitis Drug--Update
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent